|
CDC16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.613410E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.161800E-01 |
| Normal-vs-Stage2 |
1.889620E-01 |
| Normal-vs-Stage3 |
7.839800E-02 |
| Normal-vs-Stage4 |
1.154180E-01 |
| Stage1-vs-Stage2 |
3.237600E-01 |
| Stage1-vs-Stage3 |
1.814010E-01 |
| Stage1-vs-Stage4 |
2.635600E-01 |
| Stage2-vs-Stage3 |
9.949000E-01 |
| Stage2-vs-Stage4 |
9.544200E-01 |
| Stage3-vs-Stage4 |
9.391800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.897700E-02 |
| Normal-vs-AfricanAmerican |
3.698000E-01 |
| Normal-vs-Asian |
3.999400E-01 |
| Caucasian-vs-AfricanAmerican |
3.957900E-02 |
| Caucasian-vs-Asian |
2.688300E-02 |
| AfricanAmerican-vs-Asian |
7.096200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.228200E-01 |
| Normal-vs-Female |
1.325600E-01 |
| Male-vs-Female |
5.618800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.564000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.973200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.288000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.013770E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.899800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.434200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.176000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.666400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.035150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.534800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.726100E-02 |
| Classical-VS-Follicular |
3.719400E-01 |
| Classical-VS-Other |
9.925000E-01 |
| Classical-VS-Normal |
6.621400E-01 |
| Tall-VS-Follicular |
2.093400E-01 |
| Tall-VS-Other |
3.358200E-01 |
| Tall-VS-Normal |
1.809870E-02 |
| Follicular-VS-Other |
7.802200E-01 |
| Follicular-VS-Normal |
2.720600E-01 |
| Other-VS-Normal |
9.129000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.019620E-01 |
| Normal-vs-N1 |
8.318300E-02 |
| N0-vs-N1 |
5.557200E-01 |
|
|
